Coronavirus (COVID-19) Update: Ventilatory Management for COVID-Related Respiratory Failure

episode

JAMA Clinical Reviews not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Transrapid, Flugtaxis, Hyperloop – Warum es neuartige Verkehrstechnik so schwer hat 28 min · 22 Sep 2026 · Das Wissen | SWR

September 21, 2026: FAA Resolves Air Traffic Outage, Paramount Reaches Settlement, More 7 min · 22 Sep 2026 · Bloomberg News Now

Los 3 Casos Más Extraños de Relatos de la Noche 43 min · 22 Sep 2026 · Relatos de la Noche

The Ed Sheeranisation of Irish Economic Policy 39 min · 22 Sep 2026 · The David McWilliams Podcast

How can I stop my plants from dying? 5 min · 22 Sep 2026 · Do you really know?

Could smartphone use be giving you text neck? 4 min · 22 Sep 2026 · Do you really know?

Report any issue

Source

Recorded24 Apr 2020

Publisherjamaclinicalreviews.libsyn.com ↗

Handlerec:7722776

Show notes

Management of COVID-19-related respiratory failure differs from what is necessary for ARDS. Rather than having alveolar edema, COVID-19 patients have pulmonary vascular dysregulation. Gas exchange is severely compromised with little reduction in lung compliance. Ventilatory support for COVID-19 patients requires higher than normal tidal volumes with minimal PEEP and allowance for higher than usual serum CO2 levels. How the unique pathophysiology of respiratory failure should be treated is discussed by John J. Marini, MD, professor of medicine at the University of Minnesota.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in